FROVEX 2.5 mg film-coated tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

frovex 2.5 mg film-coated tablets

pco manufacturing ltd. - frovatriptan succinate monohydrate - film-coated tablet - 2.5 milligram(s) - selective serotonin (5ht1) agonists; frovatriptan

MIGUAR 2.5 mg film-coated tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

miguar 2.5 mg film-coated tablets

menarini international operations luxembourg s.a. - frovatriptan - film-coated tablet - 2.5 milligram(s) - selective serotonin (5ht1) agonists; frovatriptan

AMIRA 300 moclobemide 300 mg film-coated tablet blister pack Australia - inglés - Department of Health (Therapeutic Goods Administration)

amira 300 moclobemide 300 mg film-coated tablet blister pack

viatris pty ltd - moclobemide, quantity: 300 mg - tablet, film coated - excipient ingredients: maize starch; magnesium stearate; macrogol 6000; titanium dioxide; lactose monohydrate; sodium starch glycollate; hypromellose; povidone; purified talc; purified water; ethylcellulose; cetyl alcohol; hydrogen peroxide; sodium lauryl sulfate; octamethylcyclotetrasiloxane; silica dimethicone silylate; dimeticone 5000; cyclomethicone - treatment of major depression.

AMIRA 150 moclobemide 150 mg film-coated tablet blister pack Australia - inglés - Department of Health (Therapeutic Goods Administration)

amira 150 moclobemide 150 mg film-coated tablet blister pack

viatris pty ltd - moclobemide, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; purified talc; titanium dioxide; sodium starch glycollate; hypromellose; iron oxide yellow; lactose monohydrate; macrogol 6000; maize starch; purified water; ethylcellulose; cetyl alcohol; hydrogen peroxide; sodium lauryl sulfate; octamethylcyclotetrasiloxane; silica dimethicone silylate; dimeticone 5000; cyclomethicone - treatment of major depression.

Isoptin 80mg Film-coated Tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

isoptin 80mg film-coated tablets

bgp products ireland limited - verapamil hydrochloride - film-coated tablets - 80mg - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - prophylaxis and/or treatment of:-  angina pectoris, including prinzmetal’s angina (coronary spasm, vasospastic angina).  supraventricular tachycardias such as paroxysmal supraventricular tachycardia, atrial fibrillation/flutter with rapid ventricular response (except in wpw syndrome, see “contraindications”).  mild to moderate essential hypertension.

MANERIX 150 Milligram Film Coated Tablet Irlanda - inglés - HPRA (Health Products Regulatory Authority)

manerix 150 milligram film coated tablet

meda health sales ireland limited - moclobemide - film coated tablet - 150 milligram - monoamine oxidase a inhibitors

Almogran 12,5 mg Film-coated tablet Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

almogran 12,5 mg film-coated tablet

pi pharma - almotriptan-d,l-hydrogen malate - film-coated tablet - 12,5 mg - almotriptan-d,l-hydrogen malate - almotriptan

ALMOTRIPTAN tablet, film coated Estados Unidos - inglés - NLM (National Library of Medicine)

almotriptan tablet, film coated

ajanta pharma usa inc. - almotriptan malate (unii: pjp312605e) (almotriptan - unii:1o4xl5sn61) - almotriptan 6.25 mg - adults almotriptan tablets, usp are indicated for the acute treatment of migraine attacks in patients with a history of migraine with or without aura. adolescents age 12 to 17 years almotriptan tablets, usp are indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more (when untreated). almotriptan tablets should only be used where a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with almotriptan tablets, the diagnosis of migraine should be reconsidered before almotriptan tablets are administered to treat any subsequent attacks. in adolescents age 12 to 17 years, efficacy of almotriptan tablets on migraine-associated symptoms (nausea, photophobia, and phonophobia) was not established. almotriptan tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine [see contraindicat

ALMOTRIPTAN MALATE tablet, film coated Estados Unidos - inglés - NLM (National Library of Medicine)

almotriptan malate tablet, film coated

teva pharmaceuticals usa, inc. - almotriptan malate (unii: pjp312605e) (almotriptan - unii:1o4xl5sn61) - almotriptan 6.25 mg - adults almotriptan malate tablets are indicated for the acute treatment of migraine attacks in patients with a history of migraine with or without aura. adolescents age 12 to 17 years almotriptan malate tablets are indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more (when untreated). almotriptan malate tablets should only be used where a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with almotriptan malate tablets, the diagnosis of migraine should be reconsidered before almotriptan malate tablets are administered to treat any subsequent attacks. in adolescents age 12 to 17 years, efficacy of almotriptan malate tablets on migraine-associated symptoms (nausea, photophobia, and phonophobia) was not established. almotriptan malate tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic

Almigren tablets film-coated Armenia - inglés - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

almigren tablets film-coated

chanelle medical - almotriptan (almotriptan malate) - tablets film-coated - 12,5mg